Our team will be participating to the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT).
We will be presenting two posters:
- Abstract 837:Generation of Allogeneic CAR T-Cells Using an Easy, Safe, and Effective Non-Gene Editing Technology. Poster presentation during the Immune Targeting and Approaches with Genetically-Modified Cells and Cell Therapies Poster Session on Wednesday May 8 (12:00 PM).
- Abstract 1800: PSMA/NKG2DL Tandem CAR T-cells to overcome antigen heterogeneity and improve anti-tumor efficacy against prostate cancer. Poster presentation during the Immune Targeting and Approaches with Genetically-Modified Cells and Cell Therapies Poster Session on Friday May 10 (12:00 PM).
